As Biologics and Complex Modalities Rise, Traditional Small-Molecule CDMOs Pivot to Stay Competitive
The global active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) market is experiencing sustained expansion as pharmaceutical innovators increasingly outsource complex synthesis, scale-up, and regulatory-compliant production to specialized partners. The global active pharmaceutical ingredient CDMO market size was valued at USD 108.14 billion in 2024,...
0 Commenti 0 condivisioni 15 Views 0 Anteprima